**Core Concept**
The development of resistance to antiviral medications, such as acyclovir, involves genetic mutations in the viral genome that alter the function of essential proteins. In the case of acyclovir, resistance is primarily mediated through changes in a viral enzyme responsible for the activation of the drug.

**Why the Correct Answer is Right**
Acyclovir is a nucleoside analog that requires activation by the viral enzyme thymidine kinase (TK) to form its active form. The activated acyclovir then acts as a chain terminator during viral DNA replication. Resistance to acyclovir is most commonly due to mutations in the viral TK gene, leading to a non-functional or altered enzyme that cannot efficiently activate the drug. This results in the accumulation of defective viral DNA and a reduced ability of the virus to replicate.

**Why Each Wrong Option is Incorrect**
**Option A:** Thymidylate synthase - This enzyme is involved in the synthesis of thymidine from uracil, but it is not directly involved in the activation of acyclovir.
**Option B:** DNA polymerase - While DNA polymerase is a critical enzyme in viral DNA replication, mutations in this gene do not directly contribute to resistance against acyclovir.
**Option C:** Uracil phosphoribosyltransferase - This enzyme is involved in the salvage pathway of pyrimidine synthesis, but it is not directly involved in the activation of acyclovir.

**Clinical Pearl / High-Yield Fact**
When treating patients with acyclovir-resistant herpes simplex virus (HSV), clinicians may consider alternative antiviral medications, such as foscarnet or cidofovir, which are not affected by the same resistance mechanisms.

**Correct Answer:** C. thymidine kinase